Miproxifene

CAS : 129612-87-9

Ref. 3D-EFA61287

Informations sur le produit

• Nom: Miproxifene
• Synonymes: (Z)-alpha-(p-(2-(Dimethylamino)ethoxy)phenyl)-alpha'-ethyl-4'-isopropyl-4-stilbenol, 2-Oh-Dm-Dp, 4-[(1Z)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-buten-1-yl]phenol, 4-{(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-[4-(1-methylethyl)phenyl]but-1-en-1-yl}phenol, DP-Tat-59, Miproxifene [INN], Phenol, 4-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-(4-(1-methyletthyl)phenyl)-1-butenyl)-, (Z)-, Phenol, 4-[(1Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-buten-1-yl]-, Phenol, 4-[(1Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-butenyl]-, Phenol, 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-butenyl]-, (Z)-, Unii-Bgj4Z7930W
• CAS: 129612-87-9

Description

Miproxifene is a potent anticancer drug that has been shown to induce apoptosis and inhibit cell cycle progression in human cancer cells. This drug has been extensively studied in Chinese hamster ovary (CHO) cells and has demonstrated significant activity against various types of cancer, including leukemia. Miproxifene acts as a protein inhibitor and has been found to be effective against several tumor cell lines. It is a promising medicinal compound for the treatment of cancer, with potential applications in both chemotherapy and radiation therapy. Miproxifene is excreted primarily through urine and is well-tolerated by patients. Its use as an anticancer agent holds great promise for the future of cancer treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 429.6 g/mol
• Formule: C₂₉H₃₅NO₂
• Degré de pureté: Min. 95%